Description
Chemical name:(Z)-2-[4-(1,2-Diphenylbut-1-enyl)phenoxy]-N,N-dimethylethanamine
Formula: C26H29NO
Anabolic activity index: not a steroid
Androgenic activity index: not a steroid
TAMILONG 20mg – HAB PHARMA
Description: TAMILONG 20mg is a medication containing the active substance Tamoxifen Citrate, manufactured by HAB Pharma. Each tablet contains 20 mg of Tamoxifen Citrate and is designed for oral administration. TAMILONG is widely used in the treatment and management of hormone receptor-positive breast cancer and other conditions as determined by a healthcare provider.
Indications: TAMILONG 20mg is primarily indicated for the treatment of hormone receptor-positive breast cancer in both premenopausal and postmenopausal women. It is also used for the prevention of breast cancer in women at high risk of developing the disease. Additionally, Tamoxifen Citrate can be prescribed for other conditions such as gynecomastia and infertility due to anovulation.
Mechanism of Action: Tamoxifen Citrate, the active ingredient in TAMILONG 20mg, functions as a selective estrogen receptor modulator (SERM). It binds to estrogen receptors on cancer cells, preventing estrogen from binding and activating the receptors. This action helps inhibit the growth and proliferation of estrogen-dependent cancer cells.
Administration: TAMILONG 20mg is administered orally. The tablets should be swallowed whole with water, and they can be taken with or without food. It is important to follow the dosage and administration instructions provided by the healthcare provider.
Dosage and Treatment Plan: The dosage of TAMILONG 20mg is individualized based on the specific condition being treated, the patient’s response to therapy, and other factors such as age and overall health. Commonly, the recommended dose for breast cancer treatment is 20 mg to 40 mg per day, divided into one or two doses. For the prevention of breast cancer, the typical dosage is 20 mg per day.
Side Effects: Common side effects of TAMILONG 20mg may include hot flashes, vaginal discharge, menstrual irregularities, and nausea. More serious side effects can include an increased risk of blood clots, stroke, and endometrial cancer. Patients should report any unusual symptoms to their healthcare provider.
Precautions:
- TAMILONG 20mg should be used with caution in patients with a history of blood clots, stroke, or other cardiovascular conditions.
- It may interact with other medications, so it is important to inform the healthcare provider about all current medications, including over-the-counter drugs and supplements.
- Women who are pregnant or breastfeeding should not use TAMILONG 20mg, as it can harm the fetus or nursing infant.
Consultation with a Healthcare Provider: Before starting treatment with TAMILONG 20mg, individuals should consult with a healthcare provider or oncologist. They can provide guidance on proper usage, dosage, and potential risks associated with the medication. Regular monitoring and evaluation are essential to ensure safety and efficacy during treatment.
Reviews
There are no reviews yet.